Environmental monitoring by surface sampling for cytotoxics: a review

被引:0
作者
Petit Marie
Curti Christophe
Roche Manon
Montana Marc
Bornet Charleric
Vanelle Patrice
机构
[1] Hôpital de la Conception,Assistance Publique
[2] Aix-Marseille Université,Hôpitaux de Marseille (AP
[3] Service Central des Opérations Pharmaceutiques (SCOP),HM), Service Central de la Qualité et de l’Information Pharmaceutiques (SCQIP)
[4] Hôpital Nord,CNRS, ICR, UMR 7273, Laboratoire de Pharmaco
[5] Hôpital de la Conception,Chimie Radicalaire, Faculté de Pharmacie
来源
Environmental Monitoring and Assessment | 2017年 / 189卷
关键词
Cytotoxic drugs; Surface sampling; Chromatography; Hospital;
D O I
暂无
中图分类号
学科分类号
摘要
Environmental monitoring is usually conducted by surface sampling to detect and quantify the presence of cytotoxic drugs after their reconstitution and administration. This technique reveals the origins of residual contamination and is an important component in order to protect healthcare workers from the potential risk of occupational exposure. The aim of this work is to compare various techniques and results of surface sampling for cytotoxics. For each technique, sample processing methods and their analysis were compared from literature data. Sampling is often performed by the wiping technique. After treatment, various single or multicompound technical analyses are used, in particular liquid or gas chromatography involving different detection methods: ultraviolet, mass spectrometry, plasma torch, and voltammetry. Some methods are validated to ensure reliability. Despite published guidelines and the use of isolator technology for the preparation of cytotoxic drugs, workplace contamination persists, leading to chemotherapeutic agents’ exposure of healthcare workers. Efforts need to be maintained with particular emphasis on harmonization and on determining alert level for cytotoxic contamination.
引用
收藏
相关论文
共 298 条
[1]  
Baumann F(2006)ASHP guidelines on handling hazardous drugs American Journal of Health-System Pharmacy 63 1172-1191
[2]  
Preiss R(2001)Cyclophosphamide and related anticancer drugs BJournal of Chromatography B, Biomedical Sciences and Applications 764 173-192
[3]  
Brouwers EE(2007)Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry International Archives of Occupational and Environmental Health 80 689-699
[4]  
Huitema AD(2012)Environmental contamination with hazardous drugs in Quebec Hospitals Canadian Journal of Hospital Pharmacy 65 428-435
[5]  
Bakker EN(2008)Evaluation of occupational exposure to antiblastic drugs in an Italian hospital oncological department Journal of Occupational Health 50 48-56
[6]  
Douma JW(2005)Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees Mutation Research 587 45-51
[7]  
Schimmel KJ(2006)Hazardous anticancer drugs in health care: environmental exposure assessment Annals of the New York Academy of Sciences 1076 615-623
[8]  
Van Weringh G(2002)Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.V. Admixture area American Journal of Health-System Pharmacy 59 68-72
[9]  
Bussières JF(2005)Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies American Journal of Health-System Pharmacy 62 475-484
[10]  
Tanguay C(2010)Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers Journal of Occupational and Environmental Medicine 52 1019-1027